This issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
We hope you join this effort!
This episode includes AI-generated content.
